Longitudinal Early-Onset Alzheimer's Disease Study (LEADS) Protocol

Recruiting

40 years - 64 years

All

Phase N/A

40 participants needed

1 Location

Brief description of study

The Longitudinal Early-onset Alzheimer's Disease Study (LEADS) is a non-randomized, natural history, non-treatment study designed to look at disease progression in individuals with early onset cognitive impairment. Clinical/cognitive, imaging, biomarker, and genetic characteristics will be assessed across three cohorts: (1) early onset Alzheimer's Disease (EOAD) participants, (2) early onset non-Alzheimer's Disease (EO-nonAD) participants,and (3) cognitively normal (CN) control participants. At this time the study is only enrolling participants with cognitive impairments.

Eligibility of study

You may be eligible for this study if you meet the following criteria:

Conditions: Alzheimer's Disease,Mild Cognitive Impairment,
Age: 40 years - 64 years
Gender: All

Updated on 04 Aug 2024. Study ID: 829602

Find a site

Your Information has been sent successfully.

We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.

Would you like to be notified about other trials? Sign up for Patient Notification Services.

Send a message

Enter your contact details to connect with study team

Primary Contact

First name*

Last name*

Email*

Phone number*

Preferred way of contact

Race

Ethnicity

Are you Healthy Volunteer

Are you comfortable with the informed consent process?

Yes

Other language

By sending a message, I agree that my data will be sent to a representative for the selected site and processed in accordance with this website's Privacy Policy (see link in footer).

Longitudinal Early-Onset Alzheimer's Disease Study (LEADS) Protocol

Brief description of study

Eligibility of study

Find a site

Interested in the study